Home » Topics » Regulatory » Patents

Patents
RSS

Alchemedicine discovers CK1 and/or TGFBR1 inhibitors

Jan. 13, 2022

Roche synthesizes new Mat2A inhibitors

Jan. 13, 2022

AstraZeneca identifies new PARP-1 inhibitors

Jan. 13, 2022

Merck Sharp & Dohme presents new SCN10A blockers

Jan. 13, 2022

Autobahn Therapeutics patents thyroid hormone receptor agonists

Jan. 13, 2022

Wigen Biomedicine Technology presents new CDK inhibitors

Jan. 12, 2022

Betta Pharmaceuticals synthesizes new HIF-2alpha inhibitors

Jan. 12, 2022

Abbisko Therapeutics identifies new PD-1/PD-L1 interaction inhibitors

Jan. 12, 2022

Anaxis Pharma patents MLKL inhibitors

Jan. 12, 2022

Leo Pharma discloses IL-17 modulators

Jan. 12, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...